CIPO has published a Practice Notice regarding the handling of designated days between March and August for patents and patent applications, particularly maintenance fees and deemed abandonments.
Tag Archives: COVID
Federal Court
The Federal Court issued a COVID related Practice Notice today confirming that Practice Directions and Orders issued during the COVID-19 pandemic remain unaffected by the recently enacted Time Limits and Other Periods Act (COVID-19). See the Federal Court of Appeal’s decision last week in Re: Section 6 Of The Time Limits And Other Periods Act, 2020 FCA 137.
Federal Court of Appeal
The FCA issued a COVID related Practice Notice this week regarding in person, remote and hybrid hearings taking place this fall. It also comments on phase out of the Suspension Period at the FCA and the Time Limits and Other Periods Act (COVID-19). The FCA has been posting cases released from the Suspension Period each week.
CIPO
The Canadian Intellectual Property Office has extended the period of designated days so certain time limits will now be extended until August 24, 2020. CIPO indicates that this is the ‘final’ extension for the designated days.
CIPO
The Canadian Intellectual Property Office has again extended the period of designated days so certain time limits will now be extended until August 10, 2020.
Federal Court
The Federal Court has issued a revised COVID-19 order (see earlier post) clarifying the 2-week buffer period after the end of the Suspension Period such that timelines will be begin to run June 30 for the Western and Eastern provinces and on July 14 for Ontario, Quebec and the territories. The update also clarifies the handling of original affidavits that may have been submitted electronically.
CIPO
Federal Court
The Federal Court has indicated that the Suspension Period for Ontario, Quebec and the territories will end on June 29. The Suspension Period for the rest of Canada already ended on June 15. Continue reading Federal Court
PMPRB
The Patented Medicines Prices Review Board has released revised proposed guidelines for consultation until July 20, 2020. These guidelines are to accompany the revised Patented Medicines Regulations that are scheduled to come into force January 1, 2021. Continue reading PMPRB
Federal Court of Appeal
The Federal Court of Appeal has announced phase-out of its COVID-19 Suspension Period by identify “Selected Files” on a list to be posted each Monday starting June 22 which are released from the Suspension Period. Continue reading Federal Court of Appeal